VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
1-Year Return
23.01%
This Quarter Return
+5.59%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$169M
AUM Growth
-$13M
(-7.2%)
Cap. Flow
-$16.1M
Cap. Flow
% of AUM
-9.55%
Top 10 Holdings %
Top 10 Hldgs %
6.26%
Holding
495
New
55
Increased
122
Reduced
257
Closed
60
Top Buys
| 1 |
NVIDIA
NVDA
|
$1.21M |
| 2 |
Netflix
NFLX
|
$1.05M |
| 3 |
Meta Platforms (Facebook)
META
|
$1.04M |
| 4 |
Adobe
ADBE
|
$995K |
| 5 |
Applied Materials
AMAT
|
$977K |
Top Sells
| 1 |
ATVI
Activision Blizzard Inc.
ATVI
|
$1.01M |
| 2 |
Progressive
PGR
|
$999K |
| 3 |
Stryker
SYK
|
$984K |
| 4 |
Republic Services
RSG
|
$973K |
| 5 |
Linde
LIN
|
$966K |
Sector Composition
| 1 | Healthcare | 27.98% |
| 2 | Technology | 15.96% |
| 3 | Financials | 11.34% |
| 4 | Energy | 8.43% |
| 5 | Industrials | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
GeoPark
GPRK
$326M
| $205K | 0.12% |
20,688
-1,169
| -5% | -$11.6K |
|
302
New Jersey Resources
NJR
$4.72B
| $205K | 0.12% |
4,335
-1,630
| -27% | -$76.9K |
|
303
SunCoke Energy
SXC
$667M
| $201K | 0.12% |
25,538
-8,714
| -25% | -$68.6K |
|
304
CVR Partners
UAN
$930M
| $201K | 0.12% |
2,491
-345
| -12% | -$27.8K |
|
|
B
305
Barrick Mining Corporation
B
$48.5B
| $201K | 0.12% |
11,848
-4,980
| -30% | -$84.3K |
|
306
Crown Castle
CCI
$41.9B
| $200K | 0.12% |
1,751
-442
| -20% | -$50.4K |
|
307
Lumen
LUMN
$4.87B
| $198K | 0.12% |
87,781
+32,249
| +58% | +$72.9K |
|
308
National Storage Affiliates Trust
NSA
$2.56B
| $195K | 0.12% |
5,601
-2,514
| -31% | -$87.6K |
|
309
Newmont
NEM
$83.7B
| $194K | 0.11% |
4,537
-1,675
| -27% | -$71.5K |
|
310
Monroe Capital Corp
MRCC
$164M
| $192K | 0.11% |
23,480
-686
| -3% | -$5.61K |
|
311
Fresh Del Monte Produce
FDP
$1.72B
| $192K | 0.11% |
7,451
-3,725
| -33% | -$95.8K |
|
312
Vodafone
VOD
$28.5B
| $186K | 0.11% |
19,639
-9,320
| -32% | -$88.1K |
|
313
OFS Capital
OFS
$116M
| $185K | 0.11% |
18,700
-2,100
| -10% | -$20.8K |
|
314
ICL Group
ICL
$7.85B
| $178K | 0.11% |
32,456
-6,182
| -16% | -$33.9K |
|
|
BKCC
315
DELISTED
BlackRock Capital Investment Corporation
BKCC
| $176K | 0.1% |
53,719
+20,234
| +60% | +$66.4K |
|
316
Pan American Silver
PAAS
$14.6B
| $176K | 0.1% |
12,078
-5,422
| -31% | -$79.1K |
|
|
BCIC
317
BCP Investment Corporation Common Stock
BCIC
$160M
| $175K | 0.1% |
8,828
-739
| -8% | -$14.7K |
|
318
SuRo Capital
SSSS
$207M
| $167K | 0.1% |
52,139
-830
| -2% | -$2.65K |
|
319
Blackstone Secured Lending
BXSL
$6.72B
| $164K | 0.1% |
6,005
-1,732
| -22% | -$47.4K |
|
320
Oxford Square Capital
OXSQ
$172M
| $164K | 0.1% |
61,768
+4,947
| +9% | +$13.1K |
|
|
DICE
321
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $147K | 0.09% |
3,166
+186
| +6% | +$8.64K |
|
322
Structure Therapeutics
GPCR
$1.27B
| $146K | 0.09% |
+3,513
| New | +$146K |
|
323
Summit Therapeutics
SMMT
$19.3B
| $140K | 0.08% |
55,763
-53,998
| -49% | -$136K |
|
|
CBAY
324
DELISTED
Cymabay Therapeutics
CBAY
| $137K | 0.08% |
+12,470
| New | +$137K |
|
325
Design Therapeutics
DSGN
$367M
| $127K | 0.08% |
20,137
+8,741
| +77% | +$55.1K |
|